JPRN-UMIN000024750已完成未知
Studies of efficacy and safety of simultaneous administration of febuxostat and inosine for patients with genetic anemia, and changes of blood and urine purine compounds - Effect of febuxostat and inosine on anemia
Tsukuba International Clinical Pharmacology Clinic0 个研究点目标入组 6 人开始时间: 2017年2月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects taking azathioprine or mercaptopurine 2.Subject who has or had renal function disorder. 3.Subject with a history of gout, hyperuricemia or urolithiasis. 4.Subject who has or had hypersensitivity, idiosyncracy (allergy) to drug. 5.Subjects to whom either transfusion or surgical treatment such as splenectomy was made within 3 months before the initiation of the drug therapy. 6.Subject who was judged not to be appropriate by the principal investigator or sub investigators by other reasons.
研究者
相似试验
已完成
不适用
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with glucose intolerance, and changes of blood and urine purine compounds.JPRN-UMIN000024316Tsukuba International Clinical Pharmacology Clinic5
已完成
不适用
Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds.s disease, Parkinson'Alzheimer's disease, amyotrophic lateral sclerosis or multiple sclerosisJPRN-UMIN000024312Tsukuba International Clinical Pharmacology Clinic12
已完成
3 期
Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022Hypertension, EssentialPrimary HypercholesterolemiaNCT06448962Addpharma Inc.109
已完成
不适用
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)Influenza Virus Vaccine Adverse Reaction (Disorder)MalignancyInfluenzaNCT03061955Wake Forest University Health Sciences28
终止
2 期
Efficacy and Safety of hzVSFv13 in Patients With COVID-19 PneumoniaCOVID-19NCT04679350ImmuneMed, Inc.1